Basic Information
ID: ALA4628571
Type: Binding
Description: Induction of CRBN-mediated pLOC-ePL-tagged aiolos (unknown origin) degradation in human DF15 cells assessed as minimum protein remaining at 0.00001 uM incubated for 45 to 180 mins by luminescence based beta-galactosidase enzyme fragmentation complementation assay relative to pomalidomide
Format: BAO_0000219
Organism: Homo sapiens
Target: Cereblon/Aiolos(ALA4296167)
Document: ALA4627320
Induction of CRBN-mediated pLOC-ePL-tagged aiolos (unknown origin) degradation in human DF15 cells assessed as minimum protein remaining at 0.00001 uM incubated for 45 to 180 mins by luminescence based beta-galactosidase enzyme fragmentation complementation assay relative to pomalidomide: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4628571
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 567.62 | 3.36 | 3.36 |